PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Insuline Medical Ltd

USPTO PatentsView assignee record - 9 granted patents across 9 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Insuline ranks #29,098 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 9 technology areas.

#29,098
of 49,997 US assignees by volume
Top 42%
by Innovation Score (37.9/100)
21.1
avg claims per patent
-71%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R29098 · Foreign Corporation #29,098 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 9 grants
  • MID-PACK #29,098/49,997
  • PHOTO-FINISH Institute of…
  • CPC-NARROW A61M · 9 areas
  • INNOV-THIN 37.9/100
  • CLAIMS-DENSE 21.1 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -71% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Insuline’s 37.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Insuline

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Insuline's Innovation Score is 37.9/100 (top 42% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Insuline?

Each dot is one of Insuline’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Insuline’s own 21.1 claims/patent is ABOVE the 13.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Insuline vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 8.98.999.1 51015202530 Granted patents (volume) Avg claims / patent Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences - 9, 11.67Institute of Medi…Instituto Potosino de Investigación Científica y Tecnológica A.C. - 9, 7.78Instituto Potosin…Inston, Inc. - 9, 13.89InstonInstytut Wysokich Cisnien Polskiej Akademii Nauk - 9, 10.78Instytut Wysokich…Integra LifeSciences Enterprises, Lllp - 9, 18.22Integra Lifescien…Integrated Sensing Systems, Inc. - 9, 20.22Integrated Sensin…Integrated Solutions International, LLC - 9, 23.44Integrated Soluti…Intellishot Holdings Inc. - 9, 26.11Intellishot Holdi…Insuline Medical Ltd - 9, 21.11Insuline Medical
Insuline vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Insuline's grants concentrate

Insuline Medical Ltd is a focused PatentsView assignee: 9 CPC subclasses with 88.9% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2020. By volume, Insuline sits between Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Intellishot Holdings Inc..

Insuline's three-year grant acceleration

Insuline Medical Ltd shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Insuline's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Insuline holds 9 patents at rank #29,102, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Insuline

By rank, the assignees closest to #29,102 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Insuline's primary technology class.

Insuline's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 42% higher than 58% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20152016201720202023 1
USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Insuline Medical Ltd patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 33.3%
2016 2 22.2%
2017 2 22.2%
2020 1 11.1%
2023 1 11.1%

Which technologies does Insuline Medical Ltd patent most?

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Insuline Medical Ltd's patent record in context - here's where to go next.

  • Insuline Medical Ltd's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 88.9% of its portfolio - see every assignee active in that class. Explore A61M
  • Ranked #29,098 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Insuline Medical Ltd against Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 37.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.